Skip to Content
Merck
CN
All Photos(1)

Documents

G001635

HPLC Analysis of 3-Methylpyrazole and 4-Methylpyrazole in Urine on Discovery® C18 after SPE using Discovery® DSC-SCX

application for SPE, application for HPLC

Sign Into View Organizational & Contract Pricing

technique(s)

HPLC: suitable
solid phase extraction (SPE): suitable

test parameters

sample preparation: SPE (Solid Phase Extraction)
sample/matrix: urine spiked with 3- and 4-methylpyrazole at 1 mg/mL
SPE tube/cartridge: Discovery DSC-SCX, 500 mg/3 mL (52686-U)
condition: 2 mL methanol; 2 mL DI water
sample addition: 1 mL
washing: 2 mL DI water
elution: 2 mL 5% methanol in 250 mM potassium phosphate buffer, pH 7.4
column: Discovery C18, 15 cm × 4.6 mm, 5 μm preceded by a 2 cm guard column and 0.5 μm frit filter (504955)
mobile phase: MeOH:5 mM phosphate buffer, pH 6 (20:80)
flow rate: 1 mL/min
column temp.: 30 °C
detector: UV, 220 nm
injection: 25 μL, dilute urine extract

suitability

application for HPLC
application for SPE

application(s)

forensics and toxicology

Legal Information

Discovery is a registered trademark of Merck KGaA, Darmstadt, Germany

Analyte

Description

    3-Methylpyrazole

analytical column

related product


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service